This profile has not been claimed and data may not be accurate.
21st percentile
63rd percentile
Founding Partner of Rimon Law and angel investor backing healthcare and legal-tech
Credibility
Portfolio Scale · 50th percentile
- Publicly identified as an angel investor and strategic investor in PE and VC through YENOMI, his investment and advisory firm.
- Made at least 4 confirmed investments including Eudia, Moat Biotechnology, nSight Surgical, and Recuro Health.
Relationship Matrix
Founder score
- 95%Probability of being accurate (95%)rimonlaw.com ranks #703,598 on the Majestic Million (global domain prominence).
- 92%Probability of being accurate (92%)Current founder and CEO of Rimon Law, a global law firm he founded in 2008 and continues to lead.
- 90%Probability of being accurate (90%)Rimon Law was co-founded with Yaacov Silberman, confirming the firm had co-founders.
Investor score
- 85%Probability of being accurate (85%)Made at least 4 confirmed investments including Eudia, Moat Biotechnology, nSight Surgical, and Recuro Health.
- 80%Probability of being accurate (80%)Publicly identified as an angel investor and strategic investor in PE and VC through YENOMI, his investment and advisory firm.
What you likely need
You'd get the most out of Festival events that put you in the room with healthcare VCs, legal-tech founders, and angel syndicate operators who can help you formalize YENOMI and source co-investors. Dinners and roundtables where you can share your investment thesis publicly for the first time—among peers who will sharpen it and spread it—are your highest-leverage plays. You also benefit from structured intro sessions connecting Rimon's attorney network to early-stage founders who need both capital and legal infrastructure.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- fundraisingA dinner for first-time micro-VC and angel syndicate founders (AngelList, Synd, Stonks operators) who have recently formalized fund structures, to pressure-test whether YENOMI should register as a syndicate or micro-fund and how to attract LP capital
- introsA roundtable with healthcare-focused VCs (a16z Bio, GV, Andreessen's bio team, and specialist funds like OrbiMed) to build co-investment relationships around your Moat Biotechnology, nSight Surgical, and Recuro Health bets and get warm intros into future syndicated rounds
- positioningA dinner for investor-operators at the intersection of legal and professional-services tech—including backers of Ironclad, Clio, and Eudia—where you can publicly road-test YENOMI's investment thesis and attract inbound deal flow aligned with Rimon's portfolio
- introsA happy hour for Harvard Law and Stanford Law alumni who are now founders or early employees at legal-tech and legalOps startups, leveraging your existing speaker relationships at both schools to convert thought-leadership into proprietary deal flow for YENOMI
- positioningA roundtable for emerging angel investors with 5–15 portfolio companies who are actively building their investor brand on LinkedIn and Crunchbase, to workshop how to announce portfolio milestones like Eudia's Series A in a way that drives co-investment inbound
- tacticalA dinner for BigLaw partners and Am Law 100 firm leaders who have transitioned into or are actively angel investing, to share deal-sourcing playbooks and explore how to turn a 200-attorney network like Rimon's into a structured proprietary pipeline
- introsAn office hours session pairing health-tech founders raising seed or Series A rounds with investor-attorneys who can offer both capital and legal infrastructure, positioning YENOMI as the go-to check for founders who need a strategic law-firm partner alongside their lead VC